The re-emergence of hallucinogenic research.
Perspectives In Psychiatric Care October 2018 Matthew J Begola, Jonathan S Dowben
Due to the intractability, at times, in the treatment of PTSD, clinicians and researchers continue to explore different options for treatment. This article discusses the renewed interest in hallucinogens for such treatment.
DOI: 10.1111/ppc.12263 (opens in new tab)
Full text (opens in new tab)
MDMA
PTSD
Clinical trials
Hallucinogens